Correction: MEF2C Silencing Attenuates Load-Induced Left Ventricular Hypertrophy by Modulating mTOR/S6K Pathway in Mice.

Correction: MEF2C Silencing Attenuates Load-Induced Left Ventricular Hypertrophy by Modulating mTOR/S6K Pathway in Mice.

Bibliographic Details
Format:	Article
Language:	English
Published:	Public Library of Science (PLoS) 2014-01-01
Series:	PLoS ONE
Online Access:	http://europepmc.org/articles/PMC4210239

Similar Items

MEF2C silencing attenuates load-induced left ventricular hypertrophy by modulating mTOR/S6K pathway in mice.
by: Ana Helena M Pereira, et al.
Published: (2009-12-01)

Correction: MEF2C Silencing Attenuates Load-Induced Left Ventricular Hypertrophy by Modulating mTOR/S6K Pathway in Mice
by: The Staff
Published: (2014-01-01)

Grape juice attenuates left ventricular hypertrophy in dyslipidemic mice.
by: Ângela Maria Martins, et al.
Published: (2020-01-01)

Qindan Capsule Attenuates Myocardial Hypertrophy and Fibrosis in Pressure Overload-Induced Mice Involving mTOR and TGF-β1/Smad Signaling Pathway Inhibition
by: Wenwu Bai, et al.
Published: (2021-01-01)

Androgen interacts with exercise through the mTOR pathway to induce skeletal muscle hypertrophy
by: Fanxing Zeng, et al.
Published: (2017-12-01)

mTOR signaling pathway and mTOR inhibitors in the treatment of cancer
by: Mehmet Küçüköner, et al.
Published: (2013-03-01)

Cyclophosphamide Inhibits PI3K/AKT/mTOR Signaling Pathway in Mice Kidneys
by: Gulsah Albayrak, et al.
Published: (2018-12-01)

PI3K/AKT/mTOR pathway in Angiogenesis
by: Jayashree eKarar, et al.
Published: (2011-12-01)

The mTOR pathway is necessary for survival of mice with short telomeres
by: Iole Ferrara-Romeo, et al.
Published: (2020-03-01)

Apigenin Attenuates Adriamycin-Induced Cardiomyocyte Apoptosis via the PI3K/AKT/mTOR Pathway
by: Wei Yu, et al.
Published: (2017-01-01)

Moexipril and left ventricular hypertrophy
by: George S Chrysant, et al.
Published: (2007-03-01)

Left ventricular hypertrophy: is it really?
by: Mikolich J, et al.
Published: (2013-01-01)

mTOR signaling pathway and mTOR inhibitors in cancer: progress and challenges
by: Zhilin Zou, et al.
Published: (2020-03-01)

Propolis and swimming in the prevention of atherogenesis and left ventricular hypertrophy in hypercholesterolemic mice
by: DB. Silva, et al.

mTOR Pathways in Cancer and Autophagy
by: Mathieu Paquette, et al.
Published: (2018-01-01)

ECG DIAGNOSTICS OF LEFT VENTRICULAR HYPERTROPHY
by: E. I. Yakovenko
Published: (2009-10-01)

Apical aneurysm and left ventricular hypertrophy
by: Helena Nogueira Soufen, et al.
Published: (2000-08-01)

The production and measurement of left ventricular hypertrophy
by: McDonald, Jeremiah P.
Published: (2018)

Metabolic support in left ventricular hypertrophy
by: Howell, Neil John
Published: (2011)

Left ventricular hypertrophy: differential diagnosis
by: N.M. Nosenko, et al.
Published: (2020-03-01)

Strophanthidin Attenuates MAPK, PI3K/AKT/mTOR, and Wnt/β-Catenin Signaling Pathways in Human Cancers
by: Dhanasekhar Reddy, et al.
Published: (2020-01-01)

AKTivation of the PI3K/AKT/mTOR signaling pathway by KSHV
by: Aadra P Bhatt, et al.
Published: (2013-01-01)

Targeting the PI3K/mTOR Pathway in Pediatric Hematologic Malignancies
by: Sarah K Tasian, et al.
Published: (2014-05-01)

Silencing UHRF1 Enhances Radiosensitivity of Esophageal Squamous Cell Carcinoma by Inhibiting the PI3K/Akt/mTOR Signaling Pathway
by: Hui B, et al.
Published: (2021-06-01)

mTOR pathway in human cardiac hypertrophy caused by LEOPARD syndrome: a different role compared with animal models?
by: Hao Cui, et al.
Published: (2019-11-01)

Lysophosphatidic Acid Is Associated With Cardiac Dysfunction and Hypertrophy by Suppressing Autophagy via the LPA3/AKT/mTOR Pathway
by: Jinjing Yang, et al.
Published: (2018-09-01)

Rapamycin suppresses postnatal muscle hypertrophy induced by myostatin-inhibition accompanied by transcriptional suppression of the Akt/mTOR pathway
by: Dong hyuck Choi, et al.
Published: (2019-03-01)

An effect of left ventricular hypertrophy on mild-to-moderate left ventricular diastolic dysfunction
by: Sharma Kattel, MD, et al.
Published: (2016-03-01)

Paecilomyces cicadae-fermented Radix astragali activates podocyte autophagy by attenuating PI3K/AKT/mTOR pathways to protect against diabetic nephropathy in mice
by: Fang Yang, et al.
Published: (2020-09-01)

Paeoniflorin attenuates gestational diabetes via Akt/mTOR pathway in a rat model
by: Yonghua Zhang, et al.
Published: (2020-10-01)

Carnosine attenuates vascular smooth muscle cells calcification through mTOR signaling pathway
by: Yi Huang, et al.
Published: (2020-09-01)

KLK11 promotes the activation of mTOR and protein synthesis to facilitate cardiac hypertrophy
by: Yi Wang, et al.
Published: (2021-05-01)

Mean QRS, ventricular gradient and left ventricular mass in patients with eccentric left ventricular hypertrophy
by: Ishizawa, Kazutoshi
Published: (2017)

Involvement of PI3K/Akt/TOR pathway in stretch-induced hypertrophy of myotubes
by: SASAI, NOBUAKI, et al.
Published: (2010)

Eugenol Attenuates Cerebral Ischemia-Reperfusion Injury by Enhancing Autophagy via AMPK-mTOR-P70S6K Pathway
by: Xiaowei Sun, et al.
Published: (2020-02-01)

Wogonin Attenuates Isoprenaline-Induced Myocardial Hypertrophy in Mice by Suppressing the PI3K/Akt Pathway
by: Weichun Qian, et al.
Published: (2018-08-01)

The mTOR Signalling Pathway in Human Cancer
by: Paula Soares, et al.
Published: (2012-02-01)

Harnessing the mTOR Pathway for Tuberculosis Treatment
by: Pooja Singh, et al.
Published: (2018-01-01)

Targeting the mTOR pathway in breast cancer
by: Jia Liu, et al.
Published: (2017-06-01)

LEFT VENTRICULAR HYPERTROPHY IN PATIENTS ON CHRONIC HAEMODIALYSIS
by: A. G. Strokov, et al.
Published: (2010-06-01)

Cannot write session to /tmp/vufind_sessions/sess_ep56qs5m5a4vf0tcikkvd88f4j